A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts

Background: Warts are common cutaneous viral infection with a wide range of therapeutic modalities. Various agents have been tried for immunotherapy in warts. Objectives: Determine the role of intralesional and intradermal measles, mumps, rubella (MMR) vaccine in the treatment of common warts; to co...

Full description

Bibliographic Details
Main Authors: Pragya Gupta, Geeta Ram Tegta, G K Verma, Abhishek Gupta, Mudita Gupta, Shikha Sharma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Dermatology Online Journal
Subjects:
Online Access:http://www.idoj.in/article.asp?issn=2229-5178;year=2020;volume=11;issue=4;spage=559;epage=565;aulast=Gupta
id doaj-392e34d6fc8f42cfb83b4f7ba9a0c6c0
record_format Article
spelling doaj-392e34d6fc8f42cfb83b4f7ba9a0c6c02020-11-25T03:29:03ZengWolters Kluwer Medknow PublicationsIndian Dermatology Online Journal2229-51782020-01-0111455956510.4103/idoj.IDOJ_144_19A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common wartsPragya GuptaGeeta Ram TegtaG K VermaAbhishek GuptaMudita GuptaShikha SharmaBackground: Warts are common cutaneous viral infection with a wide range of therapeutic modalities. Various agents have been tried for immunotherapy in warts. Objectives: Determine the role of intralesional and intradermal measles, mumps, rubella (MMR) vaccine in the treatment of common warts; to compare the efficacy of intralesional versus intradermal MMR vaccine. Methods and Materials: Patients diagnosed with verruca vulgaris were divided into two groups. In study group A, the individuals were injected with an intralesional MMR vaccine of 0.3 mL in the representative wart (largest) once in 3 weeks till there is complete clearance or maximum of four injections whichever is earlier, while in study group B, the individuals were injected with an intradermal MMR vaccine of 0.3 mL over the unilateral deltoid muscle area at similar intervals. Results: There were 33 patients in each group. In group A, 10 (30.3%) patients showed complete, 9 (27.3%) marked, 6 (18.2%) moderate, 3 (9.1%) mild, and 5 (15.2%) no response. In group B, seven (21.2%) patients showed complete, one (3.0%) marked, one (3.0%) moderate, four (12.1%) mild, and 20 (60.6%) no response. There were minimal side effects in the form of pain, erythema, itching at the injection site in a few patients, only one patient had syncope. Conclusion: We conclude that the MMR vaccine is an effective and safe modality of treatment for verruca vulgaris without any serious adverse effects. Also, the intralesional route showed better results in comparison to the intradermal route when we consider the treatment of a representative wart.http://www.idoj.in/article.asp?issn=2229-5178;year=2020;volume=11;issue=4;spage=559;epage=565;aulast=Guptaimmunotherapyintradermalintralesionalmmr vaccinewart
collection DOAJ
language English
format Article
sources DOAJ
author Pragya Gupta
Geeta Ram Tegta
G K Verma
Abhishek Gupta
Mudita Gupta
Shikha Sharma
spellingShingle Pragya Gupta
Geeta Ram Tegta
G K Verma
Abhishek Gupta
Mudita Gupta
Shikha Sharma
A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
Indian Dermatology Online Journal
immunotherapy
intradermal
intralesional
mmr vaccine
wart
author_facet Pragya Gupta
Geeta Ram Tegta
G K Verma
Abhishek Gupta
Mudita Gupta
Shikha Sharma
author_sort Pragya Gupta
title A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
title_short A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
title_full A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
title_fullStr A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
title_full_unstemmed A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
title_sort study to evaluate the role of intradermal and intralesional measles, mumps, rubella (mmr) vaccine in treatment of common warts
publisher Wolters Kluwer Medknow Publications
series Indian Dermatology Online Journal
issn 2229-5178
publishDate 2020-01-01
description Background: Warts are common cutaneous viral infection with a wide range of therapeutic modalities. Various agents have been tried for immunotherapy in warts. Objectives: Determine the role of intralesional and intradermal measles, mumps, rubella (MMR) vaccine in the treatment of common warts; to compare the efficacy of intralesional versus intradermal MMR vaccine. Methods and Materials: Patients diagnosed with verruca vulgaris were divided into two groups. In study group A, the individuals were injected with an intralesional MMR vaccine of 0.3 mL in the representative wart (largest) once in 3 weeks till there is complete clearance or maximum of four injections whichever is earlier, while in study group B, the individuals were injected with an intradermal MMR vaccine of 0.3 mL over the unilateral deltoid muscle area at similar intervals. Results: There were 33 patients in each group. In group A, 10 (30.3%) patients showed complete, 9 (27.3%) marked, 6 (18.2%) moderate, 3 (9.1%) mild, and 5 (15.2%) no response. In group B, seven (21.2%) patients showed complete, one (3.0%) marked, one (3.0%) moderate, four (12.1%) mild, and 20 (60.6%) no response. There were minimal side effects in the form of pain, erythema, itching at the injection site in a few patients, only one patient had syncope. Conclusion: We conclude that the MMR vaccine is an effective and safe modality of treatment for verruca vulgaris without any serious adverse effects. Also, the intralesional route showed better results in comparison to the intradermal route when we consider the treatment of a representative wart.
topic immunotherapy
intradermal
intralesional
mmr vaccine
wart
url http://www.idoj.in/article.asp?issn=2229-5178;year=2020;volume=11;issue=4;spage=559;epage=565;aulast=Gupta
work_keys_str_mv AT pragyagupta astudytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT geetaramtegta astudytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT gkverma astudytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT abhishekgupta astudytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT muditagupta astudytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT shikhasharma astudytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT pragyagupta studytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT geetaramtegta studytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT gkverma studytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT abhishekgupta studytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT muditagupta studytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
AT shikhasharma studytoevaluatetheroleofintradermalandintralesionalmeaslesmumpsrubellammrvaccineintreatmentofcommonwarts
_version_ 1724580975840591872